New Key Statistics Module, Z-Score and F-Score
NAS:CASI Key Ratios
Market Cap $ M | 40.10 |
Enterprise Value $ M | -9.89 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.39 |
Price/Sales | 0.96 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 42.00 |
EPS (TTM) $ | -3.01 |
Beneish M-Score | -4.61 |
10-y EBITDA Growth Rate % | 2.50 |
5-y EBITDA Growth Rate % | 2.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.37 |
EV-to-EBITDA | 0.38 |
PEG | -- |
Shares Outstanding M | 13.32 |
Net Margin (%) | -95.64 |
Operating Margin % | -63.70 |
Pre-tax Margin (%) | -87.16 |
Quick Ratio | 4.17 |
Current Ratio | 4.91 |
ROA % (ttm) | -43.50 |
ROE % (ttm) | -97.69 |
ROIC % (ttm) | -68.64 |
Dividend Yield % | -- |
Altman Z-Score | -11.68 |
Piotroski F-Score | 6.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | Y |
CASI Number of Guru Trades
CASI Volume of Guru Trades
Gurus Latest Trades with NAS:CASI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CASI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CASI Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:CASI
Total 0- 1